Purification and Characterization of a Smooth Muscle Myosin Light Chain Kinase-Phosphatase Complex*

(Received for publication, June 7, 1996, and in revised form, December 19, 1996)

Apolinary Sobieszek Dagger , Jacek Borkowski § and Victoria S. Babiychuk

From the Institute of Molecular Biology, Austrian Academy of Sciences, Billrothstrasse 11, A-5020 Salzburg, Austria

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgment
REFERENCES


ABSTRACT

We show that a myofibrillar form of smooth muscle myosin light chain phosphatase (MLCPase) forms a multienzyme complex with myosin light chain kinase (MLCKase). The stability of the complex was indicated by the copurification of MLCKase and MLCPase activities through multiple steps that included myofibril preparation, gel filtration chromatography, cation (SP-Sepharose BB) and anion (Q-Sepharose FF) exchange chromatography, and affinity purification on calmodulin and on thiophosphorylated regulatory light chain columns. In addition, the purified complex eluted as a single peak from a final gel filtration column in the presence of calmodulin (CaM). Because a similar MLCPase is present in varying amounts in standard preparations of both MLCKase and myosin filaments, we have named it a kinase- and myosin-associated protein phosphatase (KAMPPase).

The KAMPPase multienzyme complex was composed of a 37-kDa catalytic (PC) subunit, a 67-kDa targeting (PT) subunit, and MLCKase with or without CaM. The approximate molar ratio of the PC and PT subunits was 1:2 with a variable and usually higher molar content of MLCKase. The targeting role of the PT subunit was directly demonstrated in binding experiments in which the PT subunit bound to both the kinase and to CaM. Its binding to CaM was, however, Ca2+-independent. MLCKase and the PT subunit potentiated activity of the PC subunit when intact myosin was used as the substrate. These data indicated that there is a Ca2+-independent interaction among the MLCPase, MLCKase, and CaM that are involved in the regulation of phosphatase activity.


INTRODUCTION

Phosphorylation of myosin by myosin light chain kinase (MLCKase)1 represents the key activation step leading to contraction of smooth muscle (for reviews, see Refs. 1-4). Relaxation or inactivation of myosin is accomplished by a myosin light chain phosphatase (MLCPase) that has a controversial identification and subunit composition (see Ref. 5). In numerous previous studies (for references, see Ref. 6), many types of cytosolic MLCPases have been purified exhibiting different specific activities toward phosphorylated myosin or isolated myosin regulatory light chain (ReLC). A common feature of all of these phosphatases seems to be the presence of not only a catalytic (PC) subunit of about 35-38 kDa but also another subunit in the range of 55-72 kDa. The function of the latter subunit has not been established. Initial attempts to classify these serine/threonine phosphatases were not very successful (7), and it appears that smooth muscle MLCPases could be either the PP1 or the PP2A type.

Several years after our initial report on the first myofibrillar MLCPase (8), we and others again turned our attention to MLCPases from smooth muscle. In our new approach, the phosphatase was purified by CaM affinity chromatography and was shown to be composed of 37-kDa catalytic and 67-kDa targeting subunits (9). The only other myofibrillar phosphatase known so far was purified and partly characterized by Alessi et al. (Ref. 10; see also Refs. 11 and 12). It is composed of three subunits: a 37-kDa catalytic subunit and two regulatory subunits of 130 and 20 kDa. Although the sequence of all three subunits has been determined, the role of the regulatory subunits is not understood (see Ref. 5). In this report, we describe further results on our myofibrillar smooth muscle protein phosphatase, which is closely associated with MLCKase and myosin filaments and is called, therefore, a kinase- and myosin-associated protein phosphatase (KAMPPase). We show for the first time that this association results in a functional multienzyme complex between these two key regulatory enzymes of smooth muscle.


MATERIALS AND METHODS

Chemicals and Protein Preparations

[gamma -32P]ATP was purchased from DuPont NEN and diluted with cold ATP of special grade (Boehringer Mannheim) to the required specific activity and concentration (13, 14). DEAE-Sepharose 6B-CL, Q-Sepharose FF, SP-Sepharose BB, Sephacryl S-200, and CNBr-activated Sepharose-4B were obtained from Pharmacia Fine Chemicals (Uppsala, Sweden). Electrophoresis reagents were purchased from Bio-Rad. The other chemicals were of analytical grade and were purchased from E. Merck (Darmstadt, Germany) or Fluka (Buchs, Switzerland). Inhibitors of protein phosphatases such as microcystin-LR and okadaic acid were purchased from LC Service Corp. (Woburn, MA).

Turkey gizzard MLCKase (8), myosin (3), and calmodulin (13), as well as phosphorylated ReLC and unphosphorylated ReLC of myosin (15), were purified as described previously. A 32P-labeled isolated ReLC or intact myosin was prepared as described (9).

The buffer (AA) used throughout this study had the following composition: 60 mM KCl, 2 mM MgCl2, 0.5 mM dithiothreitol, and 10 mM imidazole with pH adjusted to 7.5 at 4 °C. It was used, with the necessary additions, during protein purification, activity measurements, binding experiments, and all other procedures.

Phosphatase and Kinase Activity Assays

Phosphatase activity was measured by the release of 32P from labeled ReLC (or myosin) as described previously (8). The assays were carried out at 25 °C in AA buffer. The concentration of 32P-ReLC light chain was in the range of 50-150 µM. Bovine serum albumin (0.1%) was added as an inert protein carrier.

MLCKase assays were carried out as described previously (14) with intact myosin (or its isolated ReLC) chain as the substrate together with radioactive ATP. More specific details of individual assays are given in the corresponding figure legends.

The phosphatase activities were also measured by a simple modification of our MLCKase activity assays (14). This method was particularly suitable for the activity measurements of the kinase-rich multienzyme complexes. In this case, the 32P-labeling of myosin (or other substrates) only required the addition of radioactive ATP, and the dephosphorylation reaction was initiated by removal of Ca2+ with EGTA. The first time point aliquots (spotted onto 3MM chromatographic paper pieces and dropped into 5% trichloroacetic acid solution) were used for estimation of the MLCKase activity or of the 32P labeling level. From the subsequent time points (after removal of Ca2+), the phosphatase activity was evaluated.

Binding to Immobilized CaM and Other Procedures

An affinity gel centrifugation method was used for identification of the targeting subunit. Approximately 200 µl of CaM affinity gel were placed into 0.45-µm Ultrafree-MC filter units (Millipore, Bedford, MA). Equilibrations, sample applications, washings, and elutions were done by layering 350 µl of a given solution on top of the gel. After a 15-min equilibration, the gels were centrifuged for 15-30 s at 1,000 rpm in a small table top centrifuge. The washes and the eluates were analyzed by SDS-PAGE after 7-10-fold concentration of the samples with 5% trichloroacetic acid precipitation. To aid the precipitation and localization of the tiny pellet, 100 µg (10 µl) of the purified ReLC or essential light chain were added as an inert protein carrier.

Coupling of ReLC to CNBr-activated Sepharose 4B and thiophosphorylation of ReLC affinity columns as well as their elutions were performed as described (9). SDS-PAGE was performed in 7.5-15 or 9-18% gradient acrylamide minislab gels by the procedure of Matsudaira and Burgess (16) in the buffer system of Laemmli (17) with some improvements as described (18). Protein concentrations were determined by the methods of Gornall et al. (19) and Bradford (20) with a protein standard from Bio-Rad. Unless otherwise stated, all purification steps were carried out on ice or in the cold room (4 °C).


RESULTS

Purification of the MLCKase and MLCPase Complex

To obtain fraction that contained solely the high molecular weight MLCPase, the 40-55% ammonium sulfate fraction obtained from the myofibrillar MLCKase and MLCPase extract was first subjected to a gel filtration step on an AcA34 column (5.0 × 95 cm) in AA buffer. The fractions containing MLCKase and MLCPase activities eluted together as a relatively wide peak of about 350 kDa. These fractions were further purified on Q-Sepharose FF or DEAE-Sepharose 6B-CL columns as described in the preceding paper (9). Although this purification step made it possible to identify the SDS-PAGE bands corresponding to MLCPase catalytic (PC) and targeting (PT) subunits, a satisfactory separation of the kinase and the phosphatase was not obtained.

Because of the high affinity of the kinase for CaM and the expected very low affinity of the phosphatase for CaM, a CaM affinity column was used but also failed to separate the kinase from the phosphatase. In our hands, the MLCKase always, and to a varied extent, copurified with the phosphatase. However, the phosphatase, which was not bound to the CaM affinity column, was usually free of the kinase activity. The fraction that is bound to, and eluted from, CaM affinity columns in the presence of Ca2+ is dealt with in the preceding paper (9). The MLCKase preparations eluted from CaM affinity column in the absence of Ca2+ are heavily contaminated by the phosphatase, even when the columns are washed with 0.36 M salt. These MLCKase·MLCPase complexes are the subject of the present report.

Better separation of MLCKase and a kinase-phosphatase complex was obtained by application of the 350-kDa kinase-phosphatase fraction to a pair of chromatography columns (strong cation and anion exchanger) connected in tandem. After extensive washing and separate elution of these two columns, we found that most of the kinase was bound by the first column (Fig. 1A), and the reverse was true for the phosphatase. Practically all of the phosphatase activity passed through the first column and was bound by the second column (Fig. 1B). The level of KAMPPase was so high that, despite the addition of 0.5 µM microcystin-LR, the kinase activity was suppressed everywhere except in the fractions from the "ascending" and "descending" tubes outside of the phosphatase peak (Fig. 1B). On SDS-PAGE (Fig. 2B), this type of KAMPPase preparation showed the PT and PC subunits and variable amounts of the kinase (130-kDa band). In addition, CaM, tropomyosin (TM), calcimedin (Calc), and other weak bands were also present.


Fig. 1. Separation of MLCKase and MLCPase activities during cation (A) and anion (B) ionic exchange chromatography. During application and extensive washing, the two columns used were arranged in tandem, but they were eluted separately. A, the SP-Sepharose BB column (2.2 × 18 cm) was eluted by linear 0-400 mM NaCl gradient (2 × 500 ml), and 9.5-ml fractions were collected. B, the Q-Sepharose FF column (2.2 × 10 cm) was eluted by a linear 120-370 mM NaCl gradient (2 × 250 ml), and 7-ml fractions were collected. For both gradients (thin broken line), the 10 on the activity scale corresponds to 100 mM NaCl, and the buffer (AA) also contained 0.5 mM EGTA and 0.5 mM phenylmethylsulfonyl fluoride. The phosphatase activities (open circle ) were not normalized, and this activity in A was about 20-fold lower than in B. In B the kinase activities (black-diamond ) were measured with 0.5 µM of microcystin-LR added and this was not sufficient to completely suppress the KAMPPase activity.
[View Larger Version of this Image (29K GIF file)]



Fig. 2. SDS-PAGE of the protein separation during cation exchange (A) and anion exchange (B) chromatography. Except for the fraction size, the patterns correspond to those of Fig. 1.
[View Larger Version of this Image (51K GIF file)]


When the MLCKase·MLCPase complex eluted from the second anion exchange column was applied to a CaM affinity column, all of the KAMPPase activity was bound by the column, provided that the kinase content was not too low and the losses of the PT subunit resulting from proteolytic degradation were not too high. In the presence of 0.1 mM Ca2+, the activity remained bound even at 360 mM salt but could be eluted together with the kinase with a buffer containing 2 mM EGTA. The four major bands in the eluted complex corresponded to the subunits described previously (Fig. 3, lane i). The four subunits were seemingly tightly associated. No dissociation was observed even after a 3.5-h preincubation in 3.5 M LiBr (in the absence of Ca2+) followed by passage of the complex through a Sephacryl S-200 column in buffer containing 0.5 M LiBr (results not shown). Based on this observation, we believe that MLCKase and MLCPase form a multienzyme complex of the type described for other enzyme systems (21). A similar multienzyme complex was formed after dialysis of the concentrated KAMPPase fraction obtained from the DEAE- or Q-Sepharose columns (Fig. 3, lane k). Both complexes are only partly soluble at physiological salt concentrations and are bound to myosin filaments with relatively high affinity when sedimented through a 5-50% sucrose gradient (results not shown).


Fig. 3. SDS-PAGE of selected purification stages of KAMPPase and its complexes with MLCKase. The gradient gels used in this figure were made of 7.5-15% (lanes a-e) and 9-18% (lanes f-k) acrylamide. a, standard MLCKase preparation eluted from the CaM affinity column after washing of the column with 0.36 M NaCl; b, the PTC holoenzyme purified from the 0.36 M NaCl wash; c, the wash; d, the multienzyme complex after tandem ionic exchange chromatography; e, the complex after further purification on the long gamma SP affinity column; f, the PC subunit purified from the breakthrough fraction; g, PTC holoenzyme purified from the 0.36 M NaCl wash; h, the concentrated multienzyme complex after tandem ionic exchange chromatography; i, the complex after purification on CaM affinity column; j, as i after further purification on the long gamma SP-ReLC affinity column; k, pH 6.6 insoluble multienzyme complex formed by dialysis of the concentrated KAMPPase (DEAE-Sepharose) fractions dialyzed against AA buffer.
[View Larger Version of this Image (43K GIF file)]


Contamination of MLCKase by KAMPPase

Consistent with the suggested tight binding of KAMPPase to MLCKase, KAMPPase activity was present in all of the MLCKase preparations, and the bands corresponding to the two phosphatase subunits could be identified on heavily loaded SDS-PAGE gels of purified MLCKase (Fig. 3; compare lanes a and b). The presence of this endogenous KAMPPase activity in MLCKase preparations depended not only on the integrity of the PT subunit but also on the presence of CaM. In addition to the kinase, CaM was also present in the KAMPPase activity peak of the Q-Sepharose column (see Fig. 2B), but it was lost during the next ammonium sulfate concentration step when 0.5 mM EGTA was present in the elution buffer.

The presence of phosphatase activity in apparently homogenous MLCKase preparations also was shown in another type of experiment. The kinase undergoes a slow autophosphorylation (22). However, the rate and the maximal level of this autocatalytic reaction are strongly affected by the presence of this endogenous phosphatase. As shown in Fig. 4A, the autophosphorylation (rate and maximal level) could be increased 3-10-fold by adding either okadaic acid or microcystin-LR, two of the most potent protein phosphatase inhibitors (5). For standard MLCKase preparation purified from the kinase peak of the DEAE-Sepharose but not passed through CaM affinity columns, the endogenous KAMPPase present may completely inhibit the autophosphorylation. In this case, the addition of 2.5 µM okadaic acid results in a 10-fold increase in the autophosphorylation rate (Fig. 4A). The autophosphorylation also could be decreased by adding the purified KAMPPase or its PC subunit (see Ref. 9). This indicates that autophosphorylated MLCKase was a good substrate for the KAMPPase.


Fig. 4. Tight association of MLCPase activity with purified MLCKase (A and B) and its possible release by telokin (C). A, the presence of an endogenous MLCKase-phosphatase was apparent from an increase in the kinase autophosphorylation after adding phosphatase inhibitors (open circle , diamond ), controls (bullet , black-diamond ), DEAE-purified MLCKase (open circle , bullet ), or MLCKase preparation purified on CaM affinity and gel filtration columns (diamond , black-diamond ). B, effects of this endogenous phosphatase on the autophosphorylation at different CaM concentrations (inset shows that this activity could also be stimulated by CaM.) Note that at the optimal CaM concentration (10 µM), the phosphatase activity did not remain constant but increased because the autophosphorylation level of the kinase (15 µM) declined. C, effect of telokin on KAMPPase activity of the multienzyme complex (×), the PC subunit (diamond ), and PTC holoenzyme (black-diamond ). Dephosphorylation rates were measured with 32P-ReLC as the substrate. For more details see "Materials and Methods."
[View Larger Version of this Image (33K GIF file)]


Because of the presence of endogenous KAMPPase in purified MLCKase preparations, it is apparent that these preparations should also be considered as containing MLCKase·MLCPase multienzyme complexes. These types of preparations, having relatively low phosphatase content, exhibit a characteristic autophosphorylation rate change when the CaM:kinase ratio is optimal for autophosphorylation. The steep initial rise in the CaM-dependent autophosphorylation is followed by a decline (Fig. 4B). The system should, however, approach steady state at which the autophosphorylation level remains constant (e.g. Fig. 4B; CM = 0 µM). The decrease in autophosphorylation indicates that there was an increase in the KAMPPase activity that also depended on CaM. We suggest that as a result of autophosphorylation, the PC subunit may be activated or simply dissociates from the kinase. A similar or related 2-fold increase in the endogenous KAMPPase activity was observed after the addition of CaM to the kinase (Fig. 4B; inset).

We have recently shown that the addition of telokin to MLCKase increases the relative concentration of MLCKase dimers (or monomers) and decreases that of the oligomers (23). Since evidence given in the following section indicates that oligomeric species are responsible for association of MLCKase and MLCPase, telokin may facilitate dissociation of the phosphatase or its subunit from MLCKase oligomers. As shown in Fig. 4C, the addition of increasing amounts of telokin to the purified complex resulted in progressive increases in its MLCPase activity. At the same time, telokin had no effect on the phosphatase activity of the purified PC subunit or the PTC holoenzyme (Fig. 4C). We interpret this observation as telokin-induced dissociation of the KAMPPase or its PC subunit from the kinase-phosphatase complex.

Identification of the Targeting Subunit

The kinase-phosphatase complex was subjected to further purification steps, which included hydroxylapatite, gel filtration, and commonly used short (5-cm) gamma SP-ReLC affinity columns. None of these columns produced any substantial separation of the kinase from the already identified KAMPPase subunits, although several different ionic strengths were used. However, use of a long (0.9 × 60-cm) gamma SP-ReLC affinity column together with elution by a linear 120-360 mM NaCl gradient resulted in separation of the kinase-free PTC holoenzyme and the kinase-containing multienzyme complex (Fig. 4; see also Fig. 3, lanes e and j). The presence of the PT and PC subunits in both complexes indicates again that the PT subunit acted as the PC targeting subunit for the kinase. The long affinity columns amplified the small differences in the affinity of the complex for the gamma SP-ReLC light chain by introducing gel filtration effects.

Fractionation of the multienzyme complex or its components observed during simple gel filtration chromatography is shown in Fig. 6. In the absence of CaM and at 360 mM salt, some separation between the kinase and the PTC holoenzyme was observed, but not between the PT and PC subunits (Fig. 6A). This indicates that affinity of the PT subunit for the kinase was lower than that for the PC subunit. A similar separation was observed for a MLCKase preparation containing endogenous KAMPPase (Fig. 6B). The elution position of the phosphatase peak corresponded to a molecular mass of about 150 kDa. Under similar conditions, the purified PC subunit eluted as a protein of 65 kDa. In contrast, in the presence of unsaturating CaM levels, there was close comigration of the KAMPPase activity and the absorption of the multienzyme complex (Fig. 6C). The elution position of the purified KAMPPase was not affected by the addition of CaM, indicating that CaM and Ca2+ were not absolutely needed for association of the PC and PT subunits (Fig. 6C), although Ca2+ was definitely needed for CaM binding to the kinase. Thus, the 67-kDa subunit appeared to be targeting not only the kinase but also CaM and could, therefore, act as an anchor for other CaM-binding enzymes.


Fig. 6. Gel filtration of the multienzyme complex (A) and of a kinase-rich complex in the absence (B) and in the presence (C) of CaM. In A and B a Sephacryl S-200 (0.9 × 60-cm) column was eluted with AA buffer containing 0.3 M NaCl and 2 mM EGTA. To ensure maximal possible separation, a longer (0.6 × 98-cm) column was used in C. In B, note a partial separation between the first protein peak (solid line) representing mainly the kinase absorption and the KAMPPase activity (bullet ). Under the same conditions, the purified PC subunit eluted later and with a close correlation between the activity (open circle ) and the absorption (solid line; 20-fold extended scale). When CaM (2 µM) and CaCl2 (0.1 mM) were present, there was a correlation between the complex absorption (solid line) and the KAMPPase activity (open circle ). Under the same conditions, the purified PTC holoenzyme eluted later (bullet , activity; solid line, absorption).
[View Larger Version of this Image (20K GIF file)]



Fig. 5. Separation of the multienzyme subunits on a long gamma SP-ReLC affinity (0.9 × 60-cm) column eluted with a linear 50-400 mM NaCl gradient. Note that as a result of the gel filtration effect there was some separation between the kinase (the uppermost band; tube 42) and the PTC holoenzyme (tubes 46 and 50). The free PTC holoenzyme, bound much more strongly by the gel, eluted separately (tube 72). The first tubes (tubes 13-33) contained proteins not bound by the column.
[View Larger Version of this Image (48K GIF file)]


The targeting role of the PT subunit for CaM and MLCKase was also demonstrated in direct binding experiments with our miniature CaM affinity columns (see "Materials and Methods"). The purified C subunit was not bound by CaM (Fig. 7A), but in the presence of the PT subunit most of the PC subunit was bound to the column and eluted at high ionic strength (Fig. 7, B and C). The elution was preceded by washing the miniature columns with the AA buffer containing 0.1 mM Ca2+. Although not all of the PT subunit applied was bound by the miniature columns, the presence of intact kinase enhanced this binding (Fig. 7D). This indicates again that both the kinase and CaM were the targets for the PT subunit. The incomplete binding of the PC subunit in the presence of the PT subunit (Fig. 7, B and C) also could result from the limiting amount of the PT subunit present in the purified preparation loaded onto the CaM affinity columns. Degradation or modification of the PT subunit results in a doublet detected on SDS-PAGE. It is clear from the figures that only the upper band of this doublet binds to the columns.


Fig. 7. Identification of the KAMPPase-targeting subunit. Purified PC catalytic subunit (A) and PTC holoenzyme purified by gamma SP-ReLC (B) or by CaM affinity chromatography (C), as well as multienzyme complex (D), were loaded onto tiny CaM affinity columns as described under "Materials and Methods." The composition of the unbound proteins released by washing (AA buffer) are shown by the left and the middle lanes, respectively. The proteins released by subsequent elution at 0.36 mM NaCl and EGTA (2 mM) are shown by the right lanes. The samples were concentrated 15-fold by trichloroacetic acid precipitation in the presence of myosin light chains (fast moving band).
[View Larger Version of this Image (38K GIF file)]


Possible Localization of the Complex on Myosin

We have previously shown (24) that MLCKase and CaM are very tightly bound to filamentous smooth muscle myosin. As a result, the addition of Ca2+ and ATP to purified myosin leads to a very rapid phosphorylation of the regulatory light chain. In similar experiments, we showed that the MLCPase was also associated with the same type of myosin preparations. As shown in Fig. 8, after initial rapid phosphorylation, myosin becomes dephosphorylated by this endogenous phosphatase. Both enzymes are simultaneously active, and the resulting phosphorylation rate and extent depended only on the kinase and the phosphatase activities of the myosin. However, as soon as the ATP concentration becomes relatively low, the kinase no longer acts, and the phosphatase activity prevails. This results in biphasic phosphorylation progress curves (Fig. 8). Correspondingly, the duration of the high levels of phosphorylation could be extended by adding microcystin-LR (Fig. 8). At the myosin concentration used (30-50 µM), the consumption of ATP resulting from the parallel action of the two enzymes was very low. Filamentous myosin ATPase was responsible for the rapid depletion of ATP.


Fig. 8. Association of an endogenous MLCKase·CaM·MLCPase complex with purified smooth muscle myosin. The phosphorylation time course of filamentous myosin is shown with increasing concentrations of microcystin-LR (given on each curve). Note that initial rapid phosphorylation was followed by dephosphorylation due to endogenous MLCPase. This phosphatase was progressively inhibited by microcystin-LR. To accelerate the ATP hydrolysis rate of myosin (40 µM), the experiment was carried out at 35 °C.
[View Larger Version of this Image (33K GIF file)]


That the purified MLCKase·MLCPase complex or its PC subunit is very active toward phosphorylated filamentous myosin supports the hypothesis that a similar complex is responsible for the dephosphorylation of myosin filaments in vivo. This was shown in our experiments comparing these activities for the three relevant substrates, namely isolated ReLC, filamentous myosin, and actomyosin. In this case, the endogenous MLCKase or MLCPase was removed from the myosin (see Ref. 24) and actomyosin (see Ref. 25), and the complex (added before the initiation of the assay) was the only source of both the activities. As shown in Fig. 9, the complex phosphorylated all three substrates up to the maximal levels of 0.7-1.0 mol/mol and at approximately the same high rate. In contrast, the dephosphorylation rates, measured after the addition of EGTA, were very different. Under approximately the same conditions, the filamentous myosin became fully dephosphorylated within the 2-3 min following removal of Ca2+, while the isolated light chain was hardly dephosphorylated at all during the same time. Subsequent experiments showed that the intermediate dephosphorylation rate of actomyosin resulted from blocking of the phosphorylation site by F-actin, a phenomenon also observed with the isolated PC-subunit (data not shown) and which could, perhaps, be related to the latch state of myosin (for references, see Ref. 26).


Fig. 9. Phosphorylation and dephosphorylation rates of the KAMPPase multienzyme complex for the three relevant substrates. The concentration of the complex was the same for myosin and actomyosin and 2-fold higher for the ReLC. The concentration of the purified ReLC light chain was 10-fold higher than its content in actomyosin and myosin. Saturating amounts of CaM (150 nM) were present during the measurements. For experimental details see "Materials and Methods."
[View Larger Version of this Image (27K GIF file)]



DISCUSSION

Smooth Muscle Myofibrillar Type Phosphatases

During the last 10-15 years, numerous phosphatases have been purified from smooth muscle (for references, see Ref. 9). These phosphatases were not myofibrillar, because they have been extracted from the muscle cytosol. As indicated in the Introduction, the presence of a catalytic subunit of about 37 kDa and another subunit in a range of 58-72 kDa are their common features. Thus, some analogy to our myofibrillar 37- and 67-kDa phosphatase is apparent. The possible relationship between these "old" phosphatases and our myofibrillar phosphatase was discussed in the preceding paper (9). Therefore, we will restrict the present discussion to the more recent myofibrillar MLCPase of Alessi et al. (10). Partial characterization of this phosphatase appeared during the course of our study (Ref. 10; see also Ref. 12). The MLCPase extracted from gizzard muscle myofibrils was shown to contain three subunits; a 130-kDa regulatory subunit, a 37-kDa catalytic subunit, and an unidentified component of 20 kDa. Because Alessi et al. used a method of preparing myofibrils that involved less fragmentation and washing and included a 0.6 M KCl extraction step, there is some uncertainty about comparing their results with ours. It is also not clear whether or not the catalytic subunits observed in the two studies are the same. Our PC subunit eluted as an apparent dimer at low and at high ionic strength, while that of Alessi et al. (10) appears to be monomeric. Since both of the enzymes are of a myofibrillar type, have catalytic subunits of the same Mr, and are from gizzard muscle, they must be at least closely related.

The presence of the 130-kDa MLCKase band in our multienzyme complex, on the one hand, and of a 130-kDa regulatory subunit in the MLCPase preparation of Alessi et al. (10), on the other hand, raises questions. A plausible explanation would be the presence of a 130-kDa subunit comigrating with the kinase on SDS-PAGE gels. Such a subunit would have to bind CaM (as the kinase does) and have some properties similar to this enzyme but be free of MLCKase activity. We consider this possibility as unlikely because the presence of the 130-kDa band in our KAMPPase preparations was always accompanied by high levels of kinase activity. Even a lack of such activity does not necessarily mean that the kinase is completely absent. In such situations, demonstration of the kinase activity required the addition of microcystin-LR to the assay medium and high dilution of the preparations. Further studies are needed to clarify this possible controversy.

Kinase-Phosphatase Complex

One of the novel aspects of the present study is our suggestion that the two key regulatory enzymes of smooth muscle form a multienzyme complex. Our observations, including those of the preceding paper (9), together with those from other groups (references given below when applicable) can be summarized as follows: 1) presence of endogenous MLCPase activity in virtually all apparently homogenous MLCKase preparations (27); 2) copurification of the MLCKase activity with MLCPase during almost all of the purification steps (see also Ref. 28); 3) formation of a kinase-phosphatase complex that bound to the CaM affinity column in a Ca2+/CaM-dependent manner and which could not be eluted even at high salt concentrations; 4) binding of this complex to filamentous myosin; 5) presence of endogenous MLCKase and MLCPase activities on myosin filaments (3, 29); 6) common presence of a 67-kDa subunit (for references see the Introduction), which was identified here as a CaM- and MLCKase-targeting subunit.

Consistent with this hypothesis is the recent discovery that protein kinase A and protein phosphatase 2B associate together with a common targeting protein of 79 kDa (30). In addition, our recently published observations on cross-linking of MLCKase (31) and the results of light scattering measurements (32) point to properties of smooth muscle MLCKase that are particularly relevant to complex formation. These results indicate that, in solution, the kinase is oligomeric. The kinase dimers are in equilibrium with monomers and oligomers such that, under approximately physiological conditions (5 µM of MLCKase in AA buffer containing 120 mM NaCl), there are approximately 53% dimers, 45% monomers, and 2% oligomers.

The very low binding stoichiometry indicates that the phosphatase may bind predominantly to the kinase oligomers. This conclusion is consistent not only with the data showing the effect of telokin or CaM on the multienzyme complex, but also with our light scattering measurements (32). The determinations of a relative molecular weight by light scattering demonstrates that during elution from the strong cation exchange columns (the conditions facilitating separation of the phosphatase), the kinase is monomeric. This contrasts with the kinase (or the complex) eluted from the CaM affinity column that exhibited the highest relative molecular weight, i.e. the highest oligomer content (16%) (32). The CaM-dependent targeting of the PC subunit to the MLCKase oligomers is consistent with the previously observed (13) high affinity binding (or trapping) of 125I-CaM by these oligomers during gel filtration experiments. In addition, the binding of MLCKase by both cation exchange and anion exchange gels demonstrated in the present study indicates that this enzyme possesses two strong and oppositely charged domains that could be responsible for the observed oligomerization. One of these domains, not involved in the binding to an anion exchanger gel, could bind the PT subunit and, in this way, be responsible for formation of the complex.

Possible Regulatory Pathways

The regulatory potential was demonstrated by the 10-20-fold stimulation of KAMPPase activity by preincubation with micromolar concentrations of CoCl2 (9). Significantly, this activation was not observed for the multienzyme complex or for the PTC holoenzyme. This indicates not only a great regulatory potential of the targeting subunit but also that the interaction between the subunits is specific. In agreement with a recent study (33), lower and rather variable activation by CoCl2 was observed by us for the endogenous myosin phosphatase. In view of the proteolytic susceptibility of the PT subunit it is not clear whether this can be interpreted as absence of this subunit on filamentous myosin. The presence of the other subunits (i.e. CaM and MLCKase) necessary for association of the complex with myosin was demonstrated previously (24). In view of the low molar stoichiometry of the kinase to the KAMPPase it is apparent that there is more than sufficient kinase or CaM to fulfill this role.

One would expect that the association of the PC subunit within the complex should have more significant regulatory consequences than the commonly observed modification of its specific activity. We suggest that, in general, formation of the complex plays a role in the localization of the MLCPase on the myosin filaments. A possible consequence of the association of the complex with myosin filaments could be a direct, first step inhibition of the kinase by the MLCPase as suggested recently by Johnson and Snyder (4). Although we favor this suggestion, it is clear that this would be difficult to distinguish experimentally from an indirect inhibition resulting from dephosphorylation catalysis by the phosphatase. A CaM-dependent inhibition of the kinase activity at low CaM:MLCKase molar ratios has already been demonstrated (34). However, we concluded previously that the inhibition does not result from dephosphorylation catalysis by the endogenous KAMPPase. This endogenous kinase-phosphatase was, however, responsible for the observed, apparently CaM-dependent, decline of the CaM-dependent autophosphorylation levels of the kinase. Therefore, we conclude that there is a regulatory step that initially permits significant levels of autophosphorylation despite presence of the phosphatase. Elucidation of this initial inactivating step should help in understanding the regulation of the kinase and the phosphatase activities of the multienzyme complex described in the present study.


FOOTNOTES

*   These studies were supported by grants from the Austrian Science Foundation and from the East-West Program of the Austrian Ministry for Science and Research.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed: Institute of Molecular Biology, Billrothstrasse 11, A-5020 Salzburg, Austria. Tel.: +43 662 63 961 14; Fax: +43 662 63 961 40; E-mail: ASobieszek{at}oeaw.ac.at.
§   On leave from the Department of Biochemistry, Academy of Physical Education, Witelona str. 25, Wroclaw, Poland.
1   The abbreviations used are: MLCKase, myosin light chain kinase; KAMPPase, kinase-associated myosin protein phosphatase; CaM, calmodulin; MLCPase, myosin light chain phosphatase; PC, catalytic subunit of the KAMPPase; PT, CaM- and MLCKase-targeting subunit of the KAMPPase; ReLC, 20-kDa regulatory light chain of smooth muscle myosin; gamma SP-ReLC, thiophosphorylated regulatory light chain; PAGE, polyacrylamide gel electrophoresis; PTC, KAMPPase holoenzyme composed of the PT and PC subunits.

Acknowledgment

We thank Professor Malvin Stromer for corrections to the manuscript.


REFERENCES

  1. Somlyo, A. P., and Somlyo, A. V. (1994) Nature 372, 231-236 [CrossRef][Medline] [Order article via Infotrieve]
  2. Allen, B. G., and Walsh, M. P. (1994) Trends Biochem. Sci. 19, 362-368 [CrossRef][Medline] [Order article via Infotrieve]
  3. Sobieszek, A. (1994) in Airways Smooth Muscle: Biochemical Control of Contraction and Relaxation (Raeburn, D., and Gienbycz, M. A., eds), pp. 1-29, Birkhauser Verlag, Basel
  4. Johnson, J. D., and Snyder, C. H. (1995) Adv. Second Messenger Phosphoprotein Res. 30, 153-174 [Medline] [Order article via Infotrieve]
  5. Wera, S., and Hemmings, B. A. (1995) Biochem. J. 311, 17-29 [Medline] [Order article via Infotrieve]
  6. Hartshorne, D. J. (1987) in Physiology of the Gastrointestinal Tract (Johnson, L. R., ed), pp. 423-482, Raven Press, New York
  7. Pato, M. D., Adelstein, R. S., Crouch, D., Safer, B., Ingebritsen, T. S., and Cohen, P. (1983) Eur. J. Biochem. 132, 283-287 [Abstract]
  8. Sobieszek, A., and Barylko, B. (1984) in Smooth Muscle Contraction (Stephens, N. L., ed), pp. 283-316, Marcel Dekker, Inc., New York
  9. Sobieszek, A., Babiychuk, E. B., Ortner, B., and Borkowski, J. (1997) J. Biol. Chem. 272, 7027-7033 [Abstract/Free Full Text]
  10. Alessi, D., MacDougall, L. K., Sola, M. M., Ikebe, M., and Cohen, P. (1992) Eur. J. Biochem. 210, 1023-1035 [Abstract]
  11. Shimizu, H., Ito, M., Miyahara, M., Ichikawa, K., Okubo, S., Konishi, T., Naka, M., Tanaka, T., Hirano, K., Hartshorne, D. J., and Nakano, T. (1994) J. Biol. Chem. 269, 30407-30411 [Abstract/Free Full Text]
  12. Shirazi, A., Iizuka, K., Fadden, P., Mosse, C., Somlyo, A. P., Somlyo, A. V., and Haystead, T. A. J. (1994) J. Biol. Chem. 269, 31598-31606 [Abstract/Free Full Text]
  13. Sobieszek, A. (1991) J. Mol. Biol. 220, 947-957 [Medline] [Order article via Infotrieve]
  14. Sobieszek, A. (1991) Eur. J. Biochem. 199, 735-743 [Abstract]
  15. Sobieszek, A. (1988) Anal. Biochem. 172, 43-50 [Medline] [Order article via Infotrieve]
  16. Matsudaira, P. T., and Burgess, D. R. (1978) Anal. Biochem. 87, 386-396 [Medline] [Order article via Infotrieve]
  17. Laemmli, U. K. (1970) Nature. 227, 680-685 [Medline] [Order article via Infotrieve]
  18. Sobieszek, A. (1994) Electrophoresis 15, 1014-1020 [Medline] [Order article via Infotrieve]
  19. Gornall, A. G., Bardawill, C. J., and David, M. M. (1949) J. Biol. Chem. 177, 751-766 [Free Full Text]
  20. Bradford, M. M. (1976) Anal. Biochem. 72, 248-245 [CrossRef][Medline] [Order article via Infotrieve]
  21. Fersht, A. (1985) Enzyme Structure and Mechanism, pp. 39-41, W. H. Freeman and Company, New York
  22. Sobieszek, A. (1995) Biochemistry 34, 11855-11863 [Medline] [Order article via Infotrieve]
  23. Nieznanski, K., and Sobieszek, A. (1997) Biochem. J. 322, 65-71 [Medline] [Order article via Infotrieve]
  24. Sobieszek, A. (1990) J. Muscle Res. Cell Motil. 11, 114-124 [Medline] [Order article via Infotrieve]
  25. Sobieszek, A., and Small, J. V. (1977) J. Mol. Biol. 112, 559-576 [Medline] [Order article via Infotrieve]
  26. Murphy, R. A. (1994) FASEB J. 8, 311-318 [Abstract/Free Full Text]
  27. Tokui, T., Ando, S., and Ikebe, M. (1995) Biochemistry 34, 5173-5179 [Medline] [Order article via Infotrieve]
  28. Adelstein, R. S., and Klee, C. B. (1981) J. Biol. Chem. 256, 7501-7509 [Abstract/Free Full Text]
  29. Mitsui, T., Inagaki, M., and Ikebe, M. (1992) J. Biol. Chem. 267, 16727-16735 [Abstract/Free Full Text]
  30. Coghlan, V. M., Perrino, B. A., Howard, M., Langeberg, L. K., Hicks, J. B., Gallatin, W. M., and Scott, J. D. (1995) Science 267, 108-111 [Medline] [Order article via Infotrieve]
  31. Babiychuk, E. B., Babiychuk, V. S., and Sobieszek, A. (1995) Biochemistry 34, 6366-6372 [Medline] [Order article via Infotrieve]
  32. Filenko, A. M., Danilova, V. M., and Sobieszek, A. (1997) Biophys. J. in press
  33. Okubo, S., Erdödi, F., Ito, M., Ichikawa, K., Konishi, T., Nakano, T., Kawamura, T., Brautigan, D. L., and Hartshorne, D. J. (1993) Adv. Protein Phosphatases 7, 295-314
  34. Sobieszek, A., Strobl, A., Ortner, B., and Babiychuk, E. B. (1993) Biochem. J. 295, 405-411 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.